Author

Karl R. Clauser

h-index 10 View on Semantic Scholar

We have 2 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

35 Targeting HIF2-Driven Endogenous Retroviral Antigens for Immunotherapy in Kidney Cancer

It is demonstrated that HIF2 drives the expression of tumor-specific ERVs in ccRCC that are actively translated and presented on the cell surface via HLA molecules across multiple common alleles.

Qin-Qin Jiang, Gurcan Gunaydin, Vijyendra Ramesh et al. · The Oncologist · 0 citations

Open access Aug 2026

Peptide-HLA II interaction prediction for post-translationally modified peptides

PepChem, a deep learning model utilizing novel, molecular-level peptide representations that enable predictions for sidechain modifications, bridges the critical gap in PTM-aware immune recognition prediction, with immediate applications in autoimmunity, cancer, and infectious disease.

A. Dumitrescu, Dani Korpela, Adrian M. Bebenek et al. · bioRxiv · 0 citations